IBDEI0TR ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14680,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,14681,0)
 ;;=355.1^^89^897^75
 ;;^UTILITY(U,$J,358.3,14681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14681,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,14681,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,14681,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,14682,0)
 ;;=340.^^89^897^83
 ;;^UTILITY(U,$J,358.3,14682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14682,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,14682,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,14682,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,14683,0)
 ;;=729.2^^89^897^84
 ;;^UTILITY(U,$J,358.3,14683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14683,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,14683,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,14683,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,14684,0)
 ;;=053.19^^89^897^92
 ;;^UTILITY(U,$J,358.3,14684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14684,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,14684,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,14684,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,14685,0)
 ;;=310.9^^89^897^85
 ;;^UTILITY(U,$J,358.3,14685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14685,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,14685,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,14685,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,14686,0)
 ;;=332.0^^89^897^88
 ;;^UTILITY(U,$J,358.3,14686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14686,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,14686,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,14686,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,14687,0)
 ;;=250.60^^89^897^89
 ;;^UTILITY(U,$J,358.3,14687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14687,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,14687,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,14687,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,14688,0)
 ;;=356.9^^89^897^91
 ;;^UTILITY(U,$J,358.3,14688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14688,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,14688,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,14688,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,14689,0)
 ;;=780.2^^89^897^106
 ;;^UTILITY(U,$J,358.3,14689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14689,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,14689,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,14689,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,14690,0)
 ;;=724.3^^89^897^102
 ;;^UTILITY(U,$J,358.3,14690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14690,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,14690,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,14690,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,14691,0)
 ;;=780.39^^89^897^103
 ;;^UTILITY(U,$J,358.3,14691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14691,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,14691,1,5,0)
 ;;=5^Seizure
 ;;^UTILITY(U,$J,358.3,14691,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,14692,0)
 ;;=782.0^^89^897^87
 ;;^UTILITY(U,$J,358.3,14692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14692,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,14692,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,14692,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,14693,0)
 ;;=435.9^^89^897^107
 ;;^UTILITY(U,$J,358.3,14693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14693,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,14693,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,14693,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,14694,0)
 ;;=354.2^^89^897^109
 ;;^UTILITY(U,$J,358.3,14694,1,0)
 ;;=^358.31IA^5^2
